Atheroma roulette

Journal of Nuclear Cardiology

Volumn 14, Issue 3, 2007, Pages 293-297

  Strauss, H William ^a   Narula, Jagat ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; INDIUM 111; IODINE 125; LIPOCORTIN 5 TC 99M; LOW DENSITY LIPOPROTEIN; RADIOISOTOPE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ANGIOSCOPY; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EDITORIAL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; INTRAVASCULAR ULTRASOUND; ISOTOPE LABELING; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOGENESIS;

ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249660981     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.04.008     Document Type: Editorial

References (38)

1. Udelson J.E., Dilsizian V., and Bonow R.O. Chapter 13. Nuclear cardiology. In: Zipes D.P., Libby P., Bonow R.O., and Braunwald E. (Eds). Braunwald's heart disease. 7th ed. (2005), Elsevier, Philadelphia 287-327
2. Schindler T.H., Nitzsche E., Magorsaki N., Brink I., Mix M., Olschewski M., et al. Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation. Heart 89 (2003) 517-526
3. Trepels T., Zeiher A.M., and Fichtlscherer S. The endothelium and inflammation. Endothelium 13 (2006) 423-429
4. Schoen F.J. Chapter 11. Blood vessels. In: Kumar V., Abbas A.K., and Fausto N. (Eds). Robbins and Cotran pathologic basis of disease. 7th eld. (2005), Elsevier, Philadelphia 511-554
5. Glagov S., Zarins C., Giddens D.P., and Ku D.N. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 112 (1988) 1018-1031
6. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
7. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull Jr. W., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 92 (1995) 1355-1374
8. Moreno P.R., Purushothaman K.R., Sirol M., Levy A.P., and Fuster V. Neovascularization in human atherosclerosis. Circulation 113 (2006) 2245-2252
9. Tanaka A., Shimada K., Sano T., Namba M., Sakamoto T., Nishida Y., et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 45 (2005) 1594-1599
10. Mizuno K., Miyamoto A., Satomura K., Kurita A., Arai T., Sakurada M., et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 337 (1991) 809-812
11. Potkin B.N., Bartorelli A.L., Gessert J.M., Neville R.F., Almagor Y., Roberts W.C., et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 81 (1990) 1575-1585
12. Yabushita H., Bouma B.E., Houser S.L., Aretz H.T., Jang I.K., Schlendorf K.H., et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 106 (2002) 1640-1645
13. de Korte C.L., van der Steen A.F., Cespedes E.I., and Pasterkamp G. Intravascular ultrasound elastography in human arteries: initial experience in vitro. Ultrasound Med Biol 24 (1998) 401-408
14. Lipinski M.J., Amirbekian V., Frias J.C., Aguinaldo J.G., Mani V., Briley-Saebo K.C., et al. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 56 (2006) 601-610
15. Davis H.H., Heaton W.A., Siegel B.A., Mathias C.J., Joist J.H., Sherman L.A., et al. Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet 1 (1978) 1185-1187
16. Lees R.S., Lees A.M., and Strauss H.W. External imaging of human atherosclerosis. J Nucl Med 24 (1983) 154-156
17. Lees A.M., Lees R.S., Schoen F.J., Isaacsohn J.L., Fischman A.J., McKusick K.A., et al. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis 8 (1988) 461-470
18. Iuliano L., Signore A., Vallabajosula S., Colavita A.R., Camastra C., Ronga G., et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis 126 (1996) 131-141
19. Narula J., Petrov A., Bianchi C., Ditlow C.C., Lister B.C., Dilley J., et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. Circulation 92 (1995) 474-484
20. Carrio I., Pieri P.L., Narula J., Prat L., Riva P., Pedrini L., et al. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol 5 (1998) 551-557
21. Ohtsuki K., Hayase M., Akashi K., Kopiwoda S., and Strauss H.W. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 104 (2001) 203-208
22. Vallabhajosula S., Machac J., and Knesaurek K. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG). [abstract]. J Nucl Med 37 (1996) 38p
23. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., and Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26 (2001) 314-319
24. Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
25. Ogawa M., Ishino S., Mukai T., Asano D., Teramoto N., Watabe H., et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 45 (2004) 1245-1250
26. Tawakol A., Migrino R.Q., Hoffmann U., Abbara S., Houser S., Gewirtz H., et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12 (2005) 294-301
27. Kolodgie F.D., Petrov A., Virmani R., Narula N., Verjans J.W., Weber D.K., et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108 (2003) 3134-3139
28. Dunphy M.P., Freiman A., Larson S.M., and Strauss H.W. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46 (2005) 1278-1284
29. Ben-Haim S., Kupzov E., Tamir A., and Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45 (2004) 1816-1821
30. Tatsumi M., Cohade C., Nakamoto Y., and Wahl R.L. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 229 (2003) 831-837
31. Davies J.R., Rudd J.H., Fryer T.D., Graves M.J., Clark J.C., Kirkpatrick P.J., et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36 (2005) 2642-2647
32. Meirelles G., Larson S., and Strauss. Fluorodeoxyglucose uptake and calcifications in the vascular wall at PET/CT: Assessment of frequency, stability over time and association with cardiovascular risk factors. J Nucl Med 47 (2006) 126-128
33. Rudd J., Myers K., Bansilal S., Machac J., Rafique A., Farkouh M., et al. FDG PET imaging of atherosclerotic plaque inflammation is highly reproducible-implications for atherosclerosis therapy trials. J Am Coll Cardiol. (2007) In press
34. Tahara N., Kai H., Ishibashi M., Nakaura H., Kaida H., Baba K., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 (2006) 1825-1831
35. Naghavi M., Madjid M., Gul K., Siadaty M.S., Litovsky S., Willerson J.T., et al. Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques. Catheter Cardiovasc Interv 59 (2003) 52-59
36. Stefanadis C., Toutouzas K., Tsiamis E., Mitropoulos I., Tsioufis C., Kallikazaros I., et al. Thermal heterogeneity in stable human coronary atherosclerotic plaques is underestimated in vivo: the 'cooling effect' of blood flow. J Am Coll Cardiol 41 (2003) 403-408
37. Newsholme P., Gordon S., and Newsholme E.A. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 242 (1987) 631-636
38. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C.O., Lehmann K., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30 (2003) 730-736